Treb schreef op 1 december 2015 23:50:
@RT Fagron dochter JCB heeft geen/nauwelijks omzet, FDA warning letters en de nieuwbouw nog steeds niet operationeel, de derde sales director binnen een jaar, een heel salesteam ontslagen etc etc. Een andere partij is daar op ingesprongen.
www.quvapharma.com/ " QuVa Pharma, Inc. is a newly-formed national platform for sterile compounding pharmacy services led by two experienced industry executives that has received a majority equity commitment from Bain Capital Private Equity to support the company’s creation and expansion plans. As part of its formation, QuVa Pharma has acquired the assets of the compounding services division of a company leader in the field of parenteral and management services, including its state-of-the-art 503B manufacturing facility in Sugar Land, Texas.
The modern manufacturing facility provides high-quality, ready-to-use compounded sterile preparations to hospitals across the country. Built to meet the most stringent state and federal regulations, the facility is registered with the U.S. Food and Drug Administration (FDA) as an Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act. QuVa Pharma will leverage the resources and healthcare investment experience of Bain Capital Private Equity to expand its current operations and open additional locations"
dan is er de partij nog die overgenomen is door Amerisourcebergen, ook directe concurrent.
Einde oefening voor JCB nog voordat de oefening begonnen is. OMS103 avontuur is ook niet volgens plan verlopen.